Document Detail


The Coronary Venous System: An Alternate Portal to the Myocardium for Diagnostic and Therapeutic Procedures in Invasive Cardiology.
MedLine Citation:
PMID:  11096648     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Retrograde coronary venous perfusion can preserve myocardium during experimental coronary artery occlusion and has been used clinically to deliver oxygenated blood to ischemic myocardium during unstable angina or high-risk percutaneous transluminal coronary angioplasty (PTCA). Retrograde delivery of drugs accelerates coronary thrombolysis, preserves regional myocardial function, and limits infarct size in animal models. Modifications of the coronary venous retroperfusion technique have allowed access to smaller coronary venous branches and minimization of systemic effects of local drug delivery. Retrograde coronary sinus perfusion as an adjunct in high-risk coronary PTCA is limited by its inability to provide systemic hemodynamic support during circulatory collapse. Targeted and specific gene delivery to myocardium with transfection rates superior to intraarterial or systemic injection may be a promising new application for this technique. The coronary venous system can also be used for the noninvasive creation of coronary artery bypasses or the insertion of leads for left ventricular pacing. Contrast-enhanced electron beam computed tomography (EBCT) can noninvasively provide high-resolution imaging of the coronary vessels with qualitative and quantitative information on coronary venous anatomy and coronary arteriovenous relationships and may help in selecting appropriate candidates, anticipating the degree of difficulty of the procedure, and guiding the approach. Therefore, EBCT may become the imaging modality of choice for the assessment of patients considered for such strategies.
Authors:
Gerber; Kantor; Keelan; Hayes; Schwartz; Holmes
Related Documents :
17064788 - Spontaneous coronary dissection as a cause of acute coronary syndrome: evidence for non...
23820318 - Fibrinolytic therapy versus primary percutaneous coronary interventions for st-segment ...
23271458 - Improvement of left ventricular longitudinal systolic function after transcatheter aort...
23747778 - Clinical outcomes with drug-eluting and bare metal stents in patients with st-segment e...
15234398 - The additive value of tirofiban administered with the high-dose bolus in the prevention...
19685518 - N-terminal pro-b-type natriuretic peptide and inducible ischemia in the heart and soul ...
Publication Detail:
Type:  JOURNAL ARTICLE    
Journal Detail:
Title:  Current interventional cardiology reports     Volume:  2     ISSN:  1534-3103     ISO Abbreviation:  Curr Interv Cardiol Rep     Publication Date:  2000 Feb 
Date Detail:
Created Date:  2000-11-29     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100888981     Medline TA:  Curr Interv Cardiol Rep     Country:  -    
Other Details:
Languages:  ENG     Pagination:  27-37     Citation Subset:  -    
Affiliation:
Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic and Mayo Foundation, 200 First Street, SW, Rochester, MN 55905, USA. holmes.david@mayo.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The Efficacy of Directional Atherectomy Prior to Stent Implantation.
Next Document:  Fragmin and Other Low Molecular Weight Heparins in Coronary Intervention.